VisionPoint Advisory Group’s Eastman Chemical EMN Stock Holding History

VisionPoint Advisory Group’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-4	Closed	-$307	–	785
2023 Q3	$307	Buy	+4	New	+$332	﹤0.01%	647

Other funds holding EMN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

VisionPoint Advisory Group's EMN Position: Q4 2023 in Review

VisionPoint Advisory Group sold out of Eastman Chemical (EMN) in Q4 2023, closing a stake of 4 shares — an estimated $307 sold.

VisionPoint Advisory Group first reported a position in EMN in Q3 2023 and held it in 1 quarter. The position peaked at $307 in Q3 2023. 711 funds tracked by Wall St. Rank hold EMN as of Q4 2023.

VisionPoint Advisory Group reported no remaining Eastman Chemical position as of Q4 2023 after selling out during the quarter.
VisionPoint Advisory Group sold 4 Eastman Chemical shares in Q4 2023, an estimated $307.
VisionPoint Advisory Group first reported a position in Eastman Chemical in Q3 2023 and held it in 1 quarter.
VisionPoint Advisory Group's Eastman Chemical position peaked at $307 in Q3 2023.
711 funds tracked by Wall St. Rank held Eastman Chemical as of Q4 2023.

Based on VisionPoint Advisory Group's 13F filing for Q4 2023, filed 7 Feb 2024.